Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | USP2 | O75604 | 2/20 | 0.36 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.36 |
| ▸ | MAPT | P10636 | 2/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.36 |
| ▸ | LMNA | P02545 | 1/20 | 0.36 |
| ▸ | RECQL | P46063 | 1/20 | 0.36 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | HPGD | P15428 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28678561 | 0.90 | USP2 (0.38) | USP2CYP3A4MAPTSMN1; SMN2LMNA | |
| SCHEMBL17748831 | 0.85 | USP2 (0.31) | USP2CYP3A4MAPTSMN1; SMN2LMNA | |
| SCHEMBL8075980 | 0.83 | MGAM (0.34) | USP2CYP3A4MAPTSMN1; SMN2LMNA | |
| SCHEMBL21646105 | 0.83 | MAPT (0.38) | USP2CYP3A4MAPTSMN1; SMN2LMNA | |
| SCHEMBL8817523 | 0.83 | PTGS1 (0.32) | PTGS1 | |
| SCHEMBL18342532 | 0.82 | TSHR (0.31) | USP2CYP3A4MAPTSMN1; SMN2LMNA | |
| SCHEMBL18342534 | 0.82 | TSHR (0.31) | USP2CYP3A4MAPTSMN1; SMN2LMNA | |
| SCHEMBL28202021 | 0.81 | GRIK1 (0.33) | USP2CYP3A4MAPTSMN1; SMN2LMNA | |
| SCHEMBL17748850 | 0.81 | ALDH1A1 (0.35) | MAPTLMNAALDH1A1HPGD | |
| SCHEMBL10626174 | 0.78 | TSHR (0.47) | SMN1; SMN2LMNATSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250382252-A1 | ORGANIC COMPOUNDS | GIVAUDAN SA (CH) | 2025-12-18 | — | — | US | disclosed |
| WO-2024175295-A1 | DETERGENTS AND CLEANING AGENTS COMPRISING DISPERSIN AND FRAGRANCE | HENKEL AG & CO. KGAA (DE) | 2024-08-29 | — | — | WO | disclosed |
| US-10557108-B2 | Triggered release system | NOVOZYMES A/S (DK) | 2020-02-11 | — | — | US | disclosed |
| EP-3377180-B1 | CLIMBAZOLE MICROCAPSULE AND HAIR CARE COMPOSITION COMPRISING SURFACTANT AND CLIMBAZOLE | UNILEVER PLC (GB) | 2019-06-19 | — | — | EP | disclosed |
| US-20180311124-A1 | CLIMBAZOLE MICROCAPSULE AND HAIR CARE COMPOSITION COMPRISING SURFACTANT AND CLIMBAZOLE | CONOPCO, INC., D/B/A UNILEVER (US) | 2018-11-01 | — | — | US | disclosed |
| EP-3377180-A1 | CLIMBAZOLE MICROCAPSULE AND HAIR CARE COMPOSITION COMPRISING SURFACTANT AND CLIMBAZOLE | Unilever PLC (GB) | 2018-09-26 | — | — | EP | disclosed |
| EP-2254982-B1 | DETERGENT COMPOSITION COMPRISING AN ENZYME TRIGGERED RELEASE SYSTEM | UNILEVER NV (NL) | 2013-10-16 | — | — | EP | disclosed |
| EP-2262885-B1 | TRIGGERED RELEASE SYSTEM | NOVOZYMES AS (DK) | 2013-05-15 | — | — | EP | disclosed |
| CN-102946876-A | Viral inhibitor compositions for in vivo therapeutic use comprising combination of (-) -carvone, geraniol and further essential oil component | CESA ALLIANCE SA | 2013-02-27 | — | — | CN | disclosed |
| US-20110028372-A1 | Triggered Release System | NOVOZYMES A/S (DK) | 2011-02-03 | — | — | US | disclosed |
| EP-2262885-A1 | TRIGGERED RELEASE SYSTEM | Novozymes A/S (DK) | 2010-12-22 | — | — | EP | disclosed |
| EP-2254982-A1 | DETERGENT COMPOSITION COMPRISING A TRIGGERED RELEASE SYSTEM | Unilever N.V. (NL) | 2010-12-01 | — | — | EP | disclosed |
| WO-2009118329-A1 | TRIGGERED RELEASE SYSTEM | NOVOZYMES A/S (DK) | 2009-10-01 | — | — | WO | disclosed |
| WO-2009118349-A1 | DETERGENT COMPOSITION COMPRISING A TRIGGERED RELEASE SYSTEM | UNILEVER NV (NL) | 2009-10-01 | — | — | WO | disclosed |
| CN-1233947-A | Fragrance delivery system | PROCTER & GAMBLE (US) | 1999-11-03 | — | — | CN | disclosed |
| CN-1233284-A | Fragrance delivery system for liquid detergent compositions | PROCTER & GAMBLE (US) | 1999-10-27 | — | — | CN | disclosed |
| CN-1233282-A | Laundry detergent compositions comprising beta-ketoester pro-fragrances | PROCTER & GAMBLE (US) | 1999-10-27 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250382252-A1 | ORGANIC COMPOUNDS | OR10J3, TRPA1, OR51E2 | USP2 1866/4885CYP3A4 206/4885MAPT 1576/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.